Grassley Discusses Drug Pricing on CNBC, Bloomberg Ahead of Finance Committee Hearing

Webp adobestock 298161024
Adobe Stock

Grassley Discusses Drug Pricing on CNBC, Bloomberg Ahead of Finance Committee Hearing

The following press release was published by the United States Committee on Finance Ranking Member’s News on Feb. 26, 2019. It is reproduced in full below.

WASHINGTON - U.S. Senate Finance Committee Chairman Chuck Grassley of Iowa discussed drug pricing on Squawk Box on CNBC and on Bloomberg Daybreak: Americas on Bloomberg ahead of today’s Senate Finance Committee hearing titled “Drug Pricing in America: A Prescription for Change, Part II." The witness list includes top executives from seven major pharmaceutical companies including AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi. This is the largest panel of pharmaceutical CEOs in decades to sit before a congressional committee. The interviews can be found below.

Squawk Box on CNBC

Bloomberg Daybreak: Americas on Bloomberg

Source: Ranking Member’s News

More News